PMID- 3543146 OWN - NLM STAT- MEDLINE DCOM- 19870311 LR - 20190510 IS - 0022-1899 (Print) IS - 0022-1899 (Linking) VI - 155 IP - 2 DP - 1987 Feb TI - Parenteral chloroquine for treating falciparum malaria. PG - 192-201 AB - There is no information and therefore no consensus on how chloroquine should be administered to persons with severe malaria. Although widely considered dangerous, parenteral chloroquine is extensively used. We studied the acute disposition and toxicity of intravenous (iv), intramuscular (im), subcutaneous (sc), and oral chloroquine in 60 adult Zambian patients hospitalized with falciparum malaria. Plasma concentration profiles after parenteral administration were characterized by wide fluctuations between peak and trough values. Absorption of im and sc chloroquine was rapid, with a median time to peak concentration of 30 min and a peak plasma concentration five times higher than after oral administration. The pharmacokinetic data suggest that the acute toxicity of parenteral chloroquine is related to transiently high concentrations in blood and result from incomplete distribution out of a relatively small central compartment. Parenteral chloroquine may be administered safely by simply giving smaller, more-frequent doses than are currently used or, in the case of iv administration, by using continuous infusion. FAU - White, N J AU - White NJ FAU - Watt, G AU - Watt G FAU - Bergqvist, Y AU - Bergqvist Y FAU - Njelesani, E K AU - Njelesani EK LA - eng PT - Clinical Trial PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't PL - United States TA - J Infect Dis JT - The Journal of infectious diseases JID - 0413675 RN - 886U3H6UFF (Chloroquine) SB - IM MH - Administration, Oral MH - Adolescent MH - Adult MH - Brain Diseases/drug therapy/etiology MH - Chloroquine/*administration & dosage/adverse effects/metabolism/therapeutic use MH - Female MH - Humans MH - Infusions, Intravenous MH - Injections, Intramuscular MH - Injections, Subcutaneous MH - Kinetics MH - Malaria/*drug therapy MH - Male MH - Middle Aged MH - Plasmodium falciparum EDAT- 1987/02/01 00:00 MHDA- 1987/02/01 00:01 CRDT- 1987/02/01 00:00 PHST- 1987/02/01 00:00 [pubmed] PHST- 1987/02/01 00:01 [medline] PHST- 1987/02/01 00:00 [entrez] AID - 10.1093/infdis/155.2.192 [doi] PST - ppublish SO - J Infect Dis. 1987 Feb;155(2):192-201. doi: 10.1093/infdis/155.2.192.